Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 3
Bortezomib (Velcade™) in the treatment of multiple myeloma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,935 | Dovepress* | 9,935+ | 2,043 | 11,978 | |
Totals | 9,935 | 2,043 | 11,978 | ||
*Since 15 September 2006 +Since July 2016 |
View citations on Google Scholar